Today on MedNet21, we're going to discuss Skin Cancer.
The audience should expect to learn about the evaluation and management of patients with cutaneous melanoma and the role of surgery in caring for these patients.
Dates and Times
End Date: 9/25/2023
ObjectivesAs a result of this educational activity, webcast participants will be able to: Describe at least two
advantages of neoadjuvant therapy in patients with resectable Stage III/IV melanoma; List the 2 main classes of neoadjuvant therapy in patients with resectable Stage III/IV melanoma; and UNDERSTAND the diagnosis and management of cutaneous melanoma.
The Center for Continuing Medical Education (CCME) at The Ohio State University is accredited by the Accreditation Council for Continuing Medical Education (ACCME®) to provide continuing medical education for physicians
The Center for Continuing Medical Education (CCME) at The Ohio State University designates this webcasts for a maximum of 1.00 AMA PRA Category 1 Credit(s) ™. Physicians should only claim credit commensurate with the extent of their participation in the activity.
Maintenance of Certification
Successful completion of this CME activity, which includes participation in the evaluation component, enables the participant to earn up to 1.00 MOC points in the American Board of Internal Medicine’s (ABIM) Maintenance of Certification (MOC) program. Participants will earn MOC points equivalent to the amount of CME credits claimed for the activity. It is the CME activity provider’s responsibility to submit participant completion information to ACCME for the purpose of granting ABIM MOC credit.